UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 28, 2013

Biologix Hair Inc.

(Exact Name of Registrant as Specified in Its Charter)

Nevada		000-54882		27-4588540
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

82 Avenue Road, Toronto, Ontario, Canada		M5R 2H2
(Address of Principal Executive Offices)		(Zip Code)

(647) 344-5900

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 28, 2013, Biologix Hair Inc. (the “Company”) held its 2013 Annual Meeting of Stockholders (the "Annual Meeting"). Below is a summary of the proposals and corresponding votes.

Proposal One: The six director nominees received the following votes:

Nominee	For		Withheld
Ronald Holland		42,776,750		--
Michael Stocker		42,776,750		--
Wilhelm A. Keller		42,776,750		--
David G. Csumrik		42,776,750		--
Ken Zadoorian		42,776,750		--
Mark Maybank		42,776,750		--

There were no broker non-votes on this proposal.

Proposal Two: The ratification of the selection of MNP LLP as the Company's independent registered public accounting firm for the year ending December 31, 2013 received the following votes:

For		Against				Abstain
42,576,754			--				200,000

There were no broker non-votes on this proposal.

Proposal Three: The approval of the 2013 Stock Option Plan.

For		Against				Abstain
42,576,754			--				200,000

There were no broker non-votes on this proposal.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

July 1, 2013	BIOLOGIX HAIR INC.

	/s/ Ronald Holland
	Ronald Holland
	Chairman and President

BIOLOGIX HAIR INC. 8-K